- Report
- November 2024
- 282 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 389 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 486 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 197 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 192 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 387 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 387 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 390 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 149 Pages
Global
From €5383EUR$5,450USD£4,478GBP
- Report
- November 2024
- 169 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 283 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 276 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 279 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 177 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 288 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 413 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 288 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 382 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 235 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 178 Pages
Global
From €5531EUR$5,600USD£4,602GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more